Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Granulin ELISA Kit (AC3240)
Cat.#: ASET-1829
Specifications
Description Human Granulin ELISA Kit allows for the in vitro quantitative determination of human Granulin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.938 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.563-100 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2138 Rat Relaxin 3 ELISA Kit (AC3549) Quantitative inquiry ASET-2413 Mouse Has3 ELISA Kit (AC3824) Quantitative inquiry ASET-2012 Human GIRK2 ELISA Kit (AC3423) Quantitative inquiry ASET-1988 Rat Pituitary Adenylate Cyclase-Activating Polypeptide ELISA Kit (AC3399) Quantitative inquiry ASET-1224 Human HIP1 ELISA Kit (AC2635) Quantitative inquiry ASET-1111 Human HAGH ELISA Kit (AC2522) Quantitative inquiry ASET-2220 Human SOCS2 ELISA Kit (AC3631) Quantitative inquiry ASET-1748 Rat Acetylcholinesterase ELISA Kit (AC3159) Quantitative inquiry ASET-2031 Human Plexin A2 ELISA Kit (AC3442) Quantitative inquiry ASET-1781 Rat TRPM7 ELISA Kit (AC3192) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket